CASTLE BIOSCIENCES, INC.
CSTLCIK 0001447362
Revenue (TTM)
$340.9M
+3.7% YoY
Q1 Apr 2026
Net Income (TTM)
−$36.35M
−232.4% YoY
Q1 Apr 2026
EPS Diluted (TTM)
−$1.26
−233.9% YoY
Q1 Apr 2026
Gross Margin
17.0%
Q1 Apr 2026
Operating Margin
-16.8%
Q1 Apr 2026
Net Margin
-10.7%
Q1 Apr 2026
Free Cash Flow (TTM)
−$90.12M
Q1 Apr 2026
Cash
$63.76M
Q1 Apr 2026
Total Debt
$12.82M
Q1 Apr 2026
Shares Outstanding
30.33M sh
Q1 Apr 2026